Mesenchymal stem cell physiology can be affected by antibiotics: An in vitro study

Cellular and Molecular Biology

Volumn 60, Issue 4, 2014, Pages 1-7

  Pountos, Ippokratis ^a,b   Georgouli, T ^a   Henshaw, K ^a   Howard, B ^a   Giannoudis, P V ^a,b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Antibiotics; Bone healing; Mesenchymal stem cells; Non union

Indexed keywords

ALKALINE PHOSPHATASE; ANTIBIOTIC AGENT; CALCIUM; CEFUROXIME; FLUCLOXACILLIN; GENTAMICIN; METRONIDAZOLE; PENICILLIN G; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; AGED; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL FUNCTION; CELL ISOLATION; CELL LINEAGE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; FRACTURE; HUMAN; HUMAN CELL; IN VITRO STUDY; LONG BONE; MALE; MAXIMUM PLASMA CONCENTRATION; MESENCHYMAL STEM CELL; OSTEOPROGENITOR CELL; PERIPHERAL CIRCULATION; TRABECULAR BONE; ADOLESCENT; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; MESENCHYMAL STROMA CELL; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; OSTEOGENESIS; YOUNG ADULT;

EID: 84937440633     PISSN: 01455680     EISSN: 1165158X     Source Type: Journal    
DOI: 10.14715/cmb/2014.60.4.1     Document Type: Article

References (46)

1. Vos, M.C., Behrendt, M.D., Melles, D.C., Mollema, F.P., de Groot, W., Parlevliet, G., Ott, A., Horst-Kreft, D., van Belkum, A. and Verbrugh, H.A., 5 years of experience implementing a methicillin-resistant Staphylococcus aureus search and destroy policy at the largest university medical center in the Netherlands. Infect Control Hosp Epidemiol. 2009, 30: 977-84. doi: 10.1086/605921.
2. Tang, L., Zhao, C., Xiong, Y. and Wang, A., Preparation, antibacterial properties and biocompatibility studies on vancomycin-poly(D,L)-lactic loaded plates. Int Orthop. 2010, 34: 755-9. doi: 10.1007/s00264-009-0808-z.
3. Mackain-Bremner, A.A., Owens, K., Wylde, V., Bannister, G.C. and Blom, A.W., Adherence to recommendations designed to decrease intra-operative wound contamination. Ann R Coll Surg Engl. 2008, 90: 412-6. doi: 10.1308/003588408X301028.
4. Gogia, J.S., Meehan, J.P., Di Cesare PE, Jamali AA. Local antibiotic therapy in osteomyelitis. Semin Plast Surg. 2009, 23: 100-7. doi: 10.1055/s-0029-1214162.
5. Popat, K.C., Eltgroth, M., Latempa, T.J., Grimes, C.A. and Desai, T.A., Decreased Staphylococcus epidermis adhesion and increased osteoblast functionality on antibiotic-loaded titania nanotubes. Biomaterials. 2007, 28: 4880-4888. doi: 10.1016/j.biomaterials.2007.07.037
6. Nelson, C.L., The current status of material used for depot delivery of drugs. Clin Orthop Relat Res. 2004, 427: 72-8. doi: 10.1097/01.blo.0000143741.92384.18
7. Liu, S.J., Wen-Neng Ueng, S., Lin, S.S. and Chan, E.C., In vivo release of vancomycin from biodegradable beads. J Biomed Mater Res. 2002, 63: 807-13. doi: 10.1002/jbm.10406
8. Peng, K.T., Chen, C.F., Chu, I.M., Li, Y.M., Hsu, W.H., Hsu, R.W. and Chang, P.J., Treatment of osteomyelitis with teicoplanin-encapsulated biodegradable thermosensitive hydrogel nanoparticles. Biomaterials. 2010, 31: 5227-36. doi: 10.1016/j.biomaterials.2010.03.027.
9. McLaren, A.C., Alternative materials to acrylic bone cement for delivery of depot antibiotics in orthopaedic infections. Clin Orthop Relat Res. 2004, 427: 101-6. doi: 10.1097/01.blo.0000143554.56897.26
10. Krasko, M.Y., Golenser, J., Nyska, A., Nyska, M., Brin, Y.S. and Domb, A.J., Gentamicin extended release from an injectable polymeric implant. J Control Release. 2007, 117: 90-6. doi: 10.1016/j.jconrel.2006.10.010
11. Adams, K., Couch, L., Cierny, G., Calhoun, J. and Mader J.T., In vitro and in vivo evaluation of antibiotic diffusion from antibiotic-impregnated polymethylmethacrylate beads. Clin Orthop Relat Res. 1992, 278: 244-52.
12. Wahlig, H., Dingeldein, E., Bergmann, R. and Reuss, K., The release of gentamicin from polymethylmethacrylate beads. An experimental and pharmacokinetic study. J Bone Joint Surg Br. 1978, 60: 270-5.
13. Nelson, C.L., McLaren, S.G., Skinner, R.A., Smeltzer, M.S., Thomas, J.R. and Olsen K.M., The treatment of experimental osteomyelitis by surgical debridement and the implantation of calcium sulfate tobramycin pellets. J Orthop Res. 2002, 20: 643-7. doi: 10.1016/S0736-0266(01)00133-4
14. Hsieh, P.H., Chang, Y.H., Chen, S.H., Ueng, S.W. and Shih, C.H., High concentration and bioactivity of vancomycin and aztreonam eluted from Simplex cement spacers in two-stage revision of infected hip implants: a study of 46 patients at an average follow-up of 107 days. J Orthop Res. 2006, 24: 1615-21. doi: 10.1002/jor.20214
15. Chiu, F.Y. and Lin, C.F., Antibiotic-impregnated cement in revision total knee arthroplasty. A prospective cohort study of one hundred and eighty-three knees. J Bone Joint Surg Am. 2009, 91: 628-33. doi: 10.2106/JBJS.G.01570.
16. Laine, J.C., Nguyen, T.Q., Buckley, J.M. and Kim, H.T., Effects of Mixing Techniques on Vancomycin-Impregnated Polymethylmethacrylate. J Arthroplasty. 2011, 26: 1562-6. doi: 10.1016/j.arth.2011.02.011.
17. Al-Arabi, Y.B., Nader, M., Hamidian-Jahromi, A.R. and Woods, D.A., The effect of the timing of antibiotics and surgical treatment on infection rates in open long-bone fractures: a 9-year prospective study from a district general hospital. Injury. 2007, 38: 900-5. doi: http://dx.doi.org/10.1016/j.injury.2007.02.043
18. Roberts, P. and Walker, S., The British Military Surgery Pocket Book. 13th edition. Oxford University Press. Oxford, 2004, pp 125-52.
19. Pountos, I., Georgouli, T., Henshaw, K., Bird, H., Jones, E. and Giannoudis, P.V., The effect of bone morphogenetic protein-2, bone morphogenetic protein-7, parathyroid hormone, and platelet-derived growth factor on the proliferation and osteogenic differentiation of mesenchymal stem cells derived from osteoporotic bone. J Orthop Trauma. 2010, 24: 552-6. doi: 10.1097/BOT.0b013e3181efa8fe.
20. Pountos, I., Giannoudis, P.V., Jones, E., English, A., Churchman, S., Field, S., Ponchel, F., Bird, H., Emery, P. and McGonagle, D., NSAIDS inhibit in vitro MSC chondrogenesis but not osteogenesis: implications for mechanism of bone formation inhibition in man. J Cell Mol Med. 2011, 15: 525-34. doi: 10.1111/j.1582-4934.2010.01006.x.
21. Pountos, I., Georgouli, T. and Giannoudis, P.V., The effect of autologous serum obtained after fracture on the proliferation and osteogenic differentiation of mesenchymal stem cells. Cell Mol Biol (Noisy-le-grand). 2008, 54: 33-9.
22. Dupon, M., Janvier, G., Vinçon, G., Winnock, S., Demotes-Mainard, F., Capeyron, O. and Saric, J., Plasma levels of piperacillin and vancomycin used as prophylaxis in liver transplant patients. Eur J Clin Pharmacol. 1993, 45: 529-34. doi: 10.1007/BF00315309
23. McEvoy, G., AHFS drug Information. American Society of Health-System Pharmacists. ASHP: 2010. pp
24. Mavrov, G.I. and Goubenko, T.V., Treatment of pregnant women infected with syphilis with intravenous penicillin G: Pharmacokinetical and clinical study. Gynecol Obstet Invest. 2001, 52: 114-8.
25. Landersdorfer, C.B., Kirkpatrick, C.M., Kinzig-Schippers, M., Bulitta, J.B., Holzgrabe, U., Drusano, G.L. and Sörgel, F., Population pharmacokinetics at two dose levels and pharmacodynamic profiling of flucloxacillin. Antimicrob Agents Chemother. 2007, 51: 3290-7. doi: 10.1128/AAC.01410-06
26. Adam, D., Koeppe P. and Heilmann, H.D., Pharmacokinetics of amoxicillin and flucloxacillin following the simultaneous intravenous administration of 4 g and 1 g, respectively. Infection. 1983, 11: 150-4. doi: 10.1007/BF01641294
27. Gower, P.E. and Dash, C.H. The pharmacokinetics of cefuroxime after intravenous injection. Eur J Clin Pharmacol. 1977, 12: 221-7. doi: 10.1007/BF00609865
28. Brogden, R.N., Heel, R.C., Speight, T.M. and Avery, G.S., Cefuroxime: a review of its antibacterial activity, pharmacological properties and therapeutic use. Drugs. 1979, 17: 233-66. doi: 10.2165/00003495-197917040-00001
29. Houghton, G.W., Thorne, P.S., Smith, J., Templeton, R. and Collier, J., Comparison of the pharmacokinetics of metronidazole in healthy female volunteers following either a single oral or intravenous dose. Br J Clin Pharmacol. 1979, 8: 337-41. doi: 10.1111/j.1365-2125.1979.tb04715.x
30. Metronidazole datacheet http://www.medsafe.govt.nz/Profs/Datasheet/m/MetronidazoleAFTinf.pdf
31. Edin, M.L., Miclau, T., Lester, G.E., Lindsey, R.W. and Dahners, L.E., Effect of cefazolin and vancomycin on osteoblasts in vitro. Clin Orthop Relat Res. 1996, 333: 245-51. doi http://dx.doi.org/10.1097/00003086-199612000-00027
32. Antoci, V., Adams, C.S., Hickok, N.J., Shapiro, I.M. and Parvizi, J., Antibiotics for local delivery systems cause skeletal cell toxicity in vitro. Clin Orthop Relat Res. 2007, 462: 200-6. doi: 10.1097/BLO.0b013e31811ff866
33. Chang, Y., Goldberg, V.M. and Caplan, A.I., Toxic effects of gentamicin on marrow-derived human mesenchymal stem cells. Clin Orthop Relat Res. 2006, 452: 242-9. doi: 10.1097/01.blo.0000229324.75911.c7
34. Isefuku, S., Joyner, C.J. and Simpson, A.H., Gentamicin may have an adverse effect on osteogenesis. J Orthop Trauma. 2003; 17: 212-6. doi: http://dx.doi.org/10.1097/00005131-200303000-00010
35. Pedersen, J.G. and Lund, B., Effects of gentamicin and monomer on bone. An in vitro study. J Arthroplasty. 1988. 3: S63-8.
36. Ince, A., Schütze, N., Hendrich, C., Jakob, F., Eulert, J. and Löhr, J.F., Effect of polyhexanide and gentamicin on human osteoblasts and endothelial cells. Swiss Med Wkly. 2007, 137: 139-45.
37. Ince, A., Schütze, N., Karl, N., Löhr, J.F. and Eulert, J., Gentamicin negatively influenced osteogenic function in vitro. Int Orthop. 2007, 31: 223-8. doi:10.1007/s00264-006-0144-5
38. Haleem, A.A., Rouse, M.S., Lewallen, D.G., Hanssen, A.D., Steckelberg, J.M. and Patel. R., Gentamicin and vancomycin do not impair experimental fracture healing. Clin Orthop Relat Res. 2004, 427: 22-4. doi: 10.3109/17453670902884700.
39. Anagnostakos, K., Wilmes, P., Schmitt, E. and Kelm J., Elution of gentamicin and vancomycin from polymethylmethacrylate beads and hip spacers in vivo. Acta Orthop. 2009, 80: 193-7. doi: 10.3109/17453670902884700.
40. Pountos, I., Georgouli, T., Bird, H., Kontakis, G. and Giannoudis, P.V., The effect of antibiotics on bone healing: current evidence. Expert Opin Drug Saf. 2011, 10: 935-45. doi: 10.1517/14740338.2011.589833
41. Salzmann, G.M., Naal, F.D., von Knoch, F., Tuebel, J., Gradinger, R., Imhoff, A.B. and Schauwecker, J., Effects of cefuroxime on human osteoblasts in vitro. J Biomed Mater Res A. 2007, 82: 462-8. doi: 10.1002/jbm.a.31158
42. Pountos, I., Georgouli, T., Blokhuis, T.J., Pape, H.C. and Giannoudis, P.V., Pharmacological agents and impairment of fracture healing: what is the evidence? Injury. 2008, 39: 384-94. doi: 10.1016/j.injury.2007.10.035
43. Pountos, I., Georgouli, T., Calori, G.M. and Giannoudis, P.V., Do nonsteroidal anti-inflammatory drugs affect bone healing? A critical analysis. ScientificWorldJournal. 2012: 606404. doi: 10.1100/2012/606404.
44. Duewelhenke, N., Krut, O. and Eysel, P., Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines. Antimicrob Agents Chemother. 2007, 51: 54-63. doi: 10.1128/AAC.00729-05
45. Huddleston, P.M., Steckelberg, J.M., Hanssen, A.D., Rouse, M.S., Bolander, M.E. and Patel, R., Ciprofloxacin inhibition of experimental fracture healing. J Bone Joint Surg Am. 2000, 82: 161-73.
46. Lamparter, S., Slight, S.H. and Weber K.T., Doxycycline and tissue repair in rats. J Lab Clin Med. 2002, 139: 295-302. doi:10.1067/mlc.2002.122624